HRL vs OBIO · P/E 29, rev $8.96B vs rev $198.0K
Hormel Foods Corporation (HRL) versus Orchestra BioMed Holdings Inc. (OBIO) — a side-by-side from cached financials, not a winner call.
Hormel Foods Corporation (HRL) is a packaged foods company listed on NYSE.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Latest reported HRL revenue for 2026-07-26 was $8.96B. Net income was $398.8M. Revenue was up 49.4% from 2026-04-26 to 2026-07-26. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.
HRL currently screens at market cap $13.39B and trailing P/E 28.6. OBIO currently screens at market cap $231.7M.
Not investment advice. Open the HRL and OBIO stock pages for the full models.
Not investment advice.